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Legends for Supplemental Figures
Figure E1. Time course of PAP-mediated activation of pERK1/2. Studies were 
performed in media containing serum. Results are from 4 independent experiments 
*pERK1/2 / ERK1/2 (and % decrease from vehicle) vs. 5 sec time point differs at P <
0.001.
Figure E2. Long term treatment with TAS2R agonists does not cause cell death as 
determined by propidium iodide staining. Cells were treated in serum-containing media 
for 48 hrs. The MEK1/2 and ERK1/2 inhibitors (PD and GSK) were included in these 
studies since these compounds were utilized in other studies of pERK1/2 and cell growth. 
Positive controls were retinoic acid (RA, 20 µM) and SDS (100 µM). Results are from 4 
experiments. *, P < 0.001 vs. control (vehicle)
Figure E3. Extent of β-Arrestin protein knock-down with siβ-arrestin1/2 transfection. 
Shown is a representative protein immunoblot of HASM cell extracts of 4 experiments 
performed.



